[20210301]IN11619_新的《2019冠状病毒疾病国防生产法案》（DPA）行动：实施注意事项 .pdf

CRS INSIGHT Prepared for Members and Committees of Congress INSIGHTINSIGHTi i New COVID-19 Defense Production Act (DPA) Actions: Implementation Considerations March 1, 2021 The Biden Administration has taken several executive branch actions under the Defense Production Act of 1950 (DPA) to address the Coronavirus Disease 2019 (COVID-19) pandemic. Those actions suggest a revised DPA approach and raise potential implementation issues. This Insight considers those issues and policy considerations for Congress. It is intended as a companion to CRS Insight IN11593. See CRS Report R43767 for a discussion of DPA history and authorities. Recent DPA Actions The Biden Administration has issued two executive ordersE.O.s 13987 and 14001that directly reference the DPA, and other E.O.s with additional potential relevance. On February 5, 2021, White House COVID-19 Supply Chain Coordinator Timothy W. Manning elaborated on three specific DPA actions the Administration was pursuing: 1. Issuing DPA Title I priority-rated orders to support the Pfizer-BioNTech COVID-19 vaccine production and supply chain (Moderna is reportedly already receiving support under Operation Warp Speed); 2. Expanding manufact